tiprankstipranks
Trending News
More News >
BeiGene Ltd (HK:6160)
:6160
Hong Kong Market

BeiGene Ltd (6160) Similar Stocks

Compare
22 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BeiGene Ltd
HK$181.30
HK$271.83B
586.17
71.50%
14 Buy
0 Hold
0 Sell
Strong Buy
Innovent Biologics
HK$80.75
HK$139.30B
108.71
123.07%
14 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$32.54
HK$132.35B
29.19
88.31%
4 Buy
1 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$101.30
HK$288.83B
18.14
87.45%
13 Buy
1 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$39.14
HK$237.00B
45.09
121.50%
6 Buy
1 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$70.85
HK$432.51B
61.34
26.84%
4 Buy
2 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6160
BeiGene Ltd
182.30
74.90
69.74%
HK:1801
Innovent Biologics
80.75
44.25
121.23%
HK:2269
Wuxi Biologics (Cayman)
32.54
15.24
88.09%
HK:2359
WuXi AppTec Co., Ltd. Class H
101.30
47.02
86.62%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.94
20.66
113.02%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
71.30
17.60
32.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts